Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Secukinumab in Adults With Chronic Plaque Type Psoriasis With a PASI Score of 6 to 12

NCT03131570 is registered in ClinicalTrials.gov with James G. Krueger, MD, PhD as lead sponsor.

NCT NCT03131570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03131570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Secukinumab in Adults With Chronic Plaque Type Psoriasis With a PASI Score of 6 to 12
Lead sponsor
James G. Krueger, MD, PhD
Phase
Phase 2
Overall status
Completed
Start date
May 23, 2017
Completion date
June 21, 2021
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis